Philips Heartstart FR2 Refurbished

$750.00

The HeartStart FR2+ Defibrillator (“FR2+”) is a compact, lightweight, portable, and battery powered automated external defibrillator designed for use by a trained responder to treat ventricular fibrillation (VF), the most common cause of sudden cardiac arrest (SCA).

Category: Tags: ,

Description

Product Description

The HeartStart FR2+ has come to be a trusted tool of professional responders and designated response teams in the work place and public settings. Its clean, uncluttered design is optimized for fast, efficient operation and rapid delivery of defibrillation therapy. Commands are clear and concise: ideal for the layperson and trained professionals alike.

The HeartStart FR2+ offers features that make hand-off to advanced life support (ALS) seamless to ensure continuity of care for the patient. An ECG display is available, and the FR2+ can be configured to allow ALS responders to switch to a manual mode, giving them more decision-making control.

But don’t be misled by its advanced capabilities. The HeartStart FR2+ is extremely easy to use. Its design is based on years of research refined through Philips human factors experts, and user testing with the full range of responders, from healthcare professionals to lay people. In fact, hundreds of thousands of citizens are already trained and ready to help save a life with the FR2+.

Lightweight
• Weighs 5 pounds fully equipped

Rugged
• Designed for use in extreme environments and conditions

Intuitive
• 1-2-3 operation, with text and voice prompts

Capable
• Can be used on anyone of any age, including infants and children

Ever-ready
• Powered by either a long-life disposable or a rechargeable battery

Effective
• Clinically proven low-energy waveform

Ready to use

The HeartStart FR2+ is reliable and virtually maintenance-free. It automatically performs daily, weekly, and monthly self-tests of the battery, electrical components, and subsystems. A highly visible status indicator shows at a glance whether the FR2+ has passed its last self-test and is ready for use.

Optimized for challenging environments

The HeartStart FR2+ is the right choice for harsh, outdoor, or mobile use. It combines natural sounding voice instructions that are loud and clear, with text prompts on a large, bright back-lit display. This makes it ideal if you anticipate use in noisy or poorly lit settings. And at just 5.0 pounds, it’s incredibly small and lightweight so it won’t weigh you down.

Versatility

The FR2+ is designed to be highly flexible and versatile. You can tailor your FR2 to match your specific response protocol.

Infant and child defibrillation

The FR2+ can treat patients of any age. When equipped with special infant/child defibrillator pads that reduce the energy of the FR2+’s shock to a more appropriate level, you can safely treat a child or infant in cardiac arrest.

Conscious monitoring

The reusable 3-leadwire FR2+ ECG assessment module enables the professional responder to proactively use the FR2+ to assess the rhythm of patients who are not in cardiac arrest, but are conscious, breathing, and suspected of being at risk for cardiac distress. This small, lightweight monitoring solution is ideal for in- and out-of-hospital patient transport, bike medics, situations requiring long or difficult travel, fire rigs that may be staffed on occasion by paramedics, clinics and physicians’ offices.

Reliable analysis technologies

The FR2+ uses Philips’ patented SMART Analysis algorithm to assess the patient’s heart rhythm and determine if it is shockable.

Quick Shock

Research also suggests that the opportunity for survival can be improved if interruptions to CPR are minimized. The Quick Shock capability of the FR2+ readies the defibrillator within seconds to deliver a shock, reducing the time between CPR and defibrillation. No other manufacturer can deliver a shock as quickly after CPR.

Proven therapy

When a shock is advised, the FR2+ prompts the user to deliver Philips’ low-energy SMART biphasic waveform, a highly effective defibrillation therapy that is also gentle to the heart. No other external defibrillation therapy has been supported by more published studies.

 


 

Product information courtesy of the manufacturer. © 2016 Philips Healthcare, Inc. All rights reserved.